No. As of September 2026, Sprint Bioscience AB (5JA1.SG) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Sprint Bioscience AB does not pass Musaffa's business and financial screening criteria.
Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. The company is headquartered in Huddinge, Stockholm and currently employs 30 full-time employees. The company went IPO on 2014-11-07. The company is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The firm's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug development. Its pipeline is divided in two research areas: cancer metabolism and autophagy, comprising products in the phases of establishing FBDD project and in the in vivo development. The Company’s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to focus on current market needs.
Sprint Bioscience AB 5JA1.SG
€0.23 €0.02 (10.78%) 1D
Last Updated: Sep 15, 12:00 AM·XSTU
Pricing for DE stocks is delayed by 24 hours
5JA1.SG Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Sprint Bioscience AB is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Sprint Bioscience AB (5JA1.SG) Chart
Financial Metrics & Statements of Sprint Bioscience AB (5JA1.SG)
FAQ's for Sprint Bioscience AB (5JA1.SG)
As of September 2026, Sprint Bioscience AB 5JA1.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sprint Bioscience AB using these criteria to determine its compliance status.
Muslim investors may consider investing in Sprint Bioscience AB if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Sprint Bioscience AB by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Sprint Bioscience AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Sprint Bioscience AB on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Sprint Bioscience AB (5JA1.SG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.